Sanofi India partners with NHM MP to expand NCD, rare disease services
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
Approval strengthens the company’s growing international anti-infective portfolio
Supported by Plan International, the partnership will help treat over 1,000 children annually
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
Subscribe To Our Newsletter & Stay Updated